Navigation Links
MedQuist Announces Resolution of SEC Investigation
Date:3/13/2009

MOUNT LAUREL, N.J., March 13 /PRNewswire-FirstCall/ -- MedQuist Inc. (Nasdaq: MEDQ), a leading provider of medical transcription services, is pleased to announce that it has resolved the investigation by the Securities and Exchange Commission (SEC) regarding the Company's historic billing practices. Pursuant to the settlement, the Company agreed to the entry of final judgment in prospective litigation by the SEC, including an injunction against the Company from violating federal securities laws. Under the settlement, the Company will not pay any fines or penalties to the SEC, and the Company does not admit to or deny any liability or wrongdoing.

As originally reported by MedQuist in 2004, the SEC opened an investigation regarding the Company's historic billing practices after the Company announced it had undertaken an internal review of its billing practices and was delaying the filing of its annual report on Form 10-K for the year ended December 31, 2003. MedQuist cooperated fully with the SEC investigation and is pleased to conclude this matter.

Resolution of the SEC investigation follows the Company's resolution of the previously disclosed Department of Justice investigation, the previously disclosed settlements reached in the South Broward customer class action, the consolidated medical transcriptionist class action, and the Steiner shareholder class action lawsuits, and dismissal with prejudice of the Kanter shareholder derivative class action. Upon court approval and entry of final judgment in the SEC matter and medical transcriptionist litigation, the Company will have completely resolved all class action litigation and governmental investigation matters arising from the internal review of its historic billing practices.

About MedQuist:

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedQuist Reports Fourth Quarter and Year End 2008 Results
2. MedQuist Announces Resolution of the DOJ Investigation and Dismissal of Shareholder Lawsuits
3. New Jersey-Based MedQuist Pays U.S. $6.6 Million to Resolve False Claims Act Allegations
4. MedQuist and Primordial to Demonstrate Integrated Applications at RSNA
5. MedQuist and Clario Form Partnership to Integrate zVision Radiology Practice Management Software with SpeechQ for Radiology
6. MedQuist Introduces SpeechQ for Radiology Integrated with RadWorkFlow
7. MedQuist Reports Third Quarter 2008 Results
8. MedQuist Reports Second Quarter 2008 Results
9. MedQuist Announces Changes to Board of Directors
10. MedQuist Announces Declaration of $2.75 per share Dividend on Common Stock
11. Award-Winning Massachusetts Hospital Selects MedQuist Enterprise Technology for Clinical Documentation and Speech Recognition
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... 2017 , ... Occupational pesticide exposure is linked to an ... according to a study released today at the 1st Pan American Parkinson’s and ... pesticides and incidence of sporadic PD through occupational exposure. This latest study, led ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... replacement options at his office, Antoine Dental Center. Currently, patients can get single ... restrictions may apply, but patients can learn more about these offers by contacting ...
(Date:2/24/2017)... , ... February 24, 2017 , ... An in-depth computational ... the University of Pittsburgh points to eight genes that may explain why susceptibility to ... to the results of a study published today in the journal npj Schizophrenia. ...
(Date:2/24/2017)... ... , ... In the Health Care IT campaign, Robert Herjavec discusses health IT ... you will be attacked, but when.” However, he and many others involved highlight a ... Improvements in auditing and monitoring have taken security in health care a very long ...
(Date:2/24/2017)... ... , ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” ... paramedic experiences. Schanssema describes the tragedies he saw, as well as his struggles with ... Schanssema, initially unsure of the career path he wanted to take, found fulfillment in ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... , Südkorea, 23. Februar 2017 LG Innotek ... Sterilisationsaufgaben vorgestellt. Die Sterilisationsleistung beträgt das 1,5-fache des 45-mW-Moduls ... Strahlung im Bereich zwischen 200 und 280 nm und eignet ... Bakterien, indem es ihre DNA zerstört. Das Produkt von ... ...
(Date:2/23/2017)... Feb. 23, 2017 ITL Limited, ( ASX: ITD ), ... for the half year ended 31 December 2016 compared with the ... presentation can be viewed here . Highlights ... $1.04m; up 104%) Earnings per share of 2.2 ... of $17.5m (Dec 2015: $15.7m; up 11%) Profit ...
(Date:2/23/2017)... 2017 Research and Markets has announced the addition ... report to their offering. ... The latest research Menopause Drugs Price Analysis and Strategies - 2016, provides ... research answers the following questions: What are ... they positioned in the Global Menopause market? What are ...
Breaking Medicine Technology: